ATE318834T1 - Lipide mit aminoxygruppe - Google Patents

Lipide mit aminoxygruppe

Info

Publication number
ATE318834T1
ATE318834T1 AT01270543T AT01270543T ATE318834T1 AT E318834 T1 ATE318834 T1 AT E318834T1 AT 01270543 T AT01270543 T AT 01270543T AT 01270543 T AT01270543 T AT 01270543T AT E318834 T1 ATE318834 T1 AT E318834T1
Authority
AT
Austria
Prior art keywords
lipids
aminooxy group
group
acting
provides
Prior art date
Application number
AT01270543T
Other languages
English (en)
Inventor
Michael Jorgensen
Michael Keller
Andrew David Miller
Eric Perouzel
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2000/004767 external-priority patent/WO2001048233A1/en
Priority claimed from GB0113781A external-priority patent/GB2372502B/en
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE318834T1 publication Critical patent/ATE318834T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01270543T 2000-12-12 2001-12-05 Lipide mit aminoxygruppe ATE318834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2000/004767 WO2001048233A1 (en) 1999-12-23 2000-12-12 Viral core protein-cationic lipid-nucleic acid-delivery complexes
GB0113781A GB2372502B (en) 2000-12-12 2001-06-06 Carbohydrate compounds containing cholesterol and their use

Publications (1)

Publication Number Publication Date
ATE318834T1 true ATE318834T1 (de) 2006-03-15

Family

ID=26243759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270543T ATE318834T1 (de) 2000-12-12 2001-12-05 Lipide mit aminoxygruppe

Country Status (11)

Country Link
EP (1) EP1351972B1 (de)
JP (2) JP2004522722A (de)
CN (2) CN1524125A (de)
AT (1) ATE318834T1 (de)
AU (3) AU2002222128B2 (de)
CA (2) CA2364392A1 (de)
DE (1) DE60117465T2 (de)
ES (1) ES2259007T3 (de)
HK (1) HK1057048A1 (de)
RU (2) RU2290409C2 (de)
WO (2) WO2002048170A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129121D0 (en) * 2001-12-05 2002-01-23 Ic Vec Ltd Compound
EP1877100A2 (de) * 2005-04-25 2008-01-16 GE Healthcare AS Liposomen
JP5069920B2 (ja) * 2007-02-08 2012-11-07 公益財団法人東京都医学総合研究所 マンノース６−リン酸−ポリエチレングリコール結合体
GB2458473A (en) 2008-03-17 2009-09-23 Imuthes Ltd 3'-O-allyl- and 3'-O-carboxymethyl- 2'-aminosaccharide derivatives, & amides thereof with peptides, as adjuvants
GB0908963D0 (en) 2009-05-22 2009-07-01 Imuthes Ltd Compositions
JP5936002B2 (ja) 2010-11-19 2016-06-15 北海道公立大学法人 札幌医科大学 組合わせ医薬製剤
CZ307452B6 (cs) * 2016-11-03 2018-09-05 Vysoká škola chemicko-technologická v Praze Aminooxylipidy pro konstrukci samoskladných liposomálních systémů umožňujících jejich následnou modifikaci biologicky funkčními molekulami

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31160A0 (en) * 1967-12-04 1969-01-29 Bayer Ag Basically substituted oximes of 5h-dibenzo-(a,d)-10,11-dihydro-cyclohepten-5-one and their production
NL6818074A (de) * 1968-12-17 1970-06-19
GB1322987A (en) * 1969-12-29 1973-07-11 Richter Gedeon Vegyeszet On,n-diacylhydroxylamine derivatives and preparation
US4189431A (en) * 1975-08-04 1980-02-19 The Board of Trustees of Leland Stanford Junior University Alkinyl terminating groups in biogenetic-like cyclizations to steroids
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5510510A (en) * 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
US6756054B1 (en) * 1996-05-24 2004-06-29 Ic-Vec Limited Polycationic sterol derivatives as transfection agents
JP3903392B2 (ja) * 1996-12-24 2007-04-11 サーナ・セラピューティクス・インコーポレイテッド ヌクレオシド類似体の化学合成とそのポリヌクレオチドへの導入

Also Published As

Publication number Publication date
JP2004520301A (ja) 2004-07-08
WO2002048170A1 (en) 2002-06-20
HK1057048A1 (en) 2004-03-12
WO2002048380A2 (en) 2002-06-20
CA2431896A1 (en) 2002-06-20
CN1489597A (zh) 2004-04-14
CA2364392A1 (en) 2002-06-12
EP1351972B1 (de) 2006-03-01
CN100482676C (zh) 2009-04-29
RU2003120456A (ru) 2005-01-27
JP2004522722A (ja) 2004-07-29
EP1351972A1 (de) 2003-10-15
AU2002222128B2 (en) 2007-06-21
CN1524125A (zh) 2004-08-25
AU2212802A (en) 2002-06-24
RU2003120455A (ru) 2005-01-10
AU2002220894A1 (en) 2002-06-24
DE60117465D1 (de) 2006-04-27
WO2002048380A3 (en) 2002-10-24
RU2290409C2 (ru) 2006-12-27
ES2259007T3 (es) 2006-09-16
DE60117465T2 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
AU2002232788A1 (en) Self forming, thermodynamically stable liposomes and their applications
WO2002072011A3 (en) Stabilized therapeutic and imaging agents
EA200300337A1 (ru) Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
WO2000015256A3 (fr) Emulsion immunostimulante
BR0011626A (pt) Acionamento
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
NO20021205D0 (no) Faste lipid formuleringer
AU3874300A (en) Dynamic ad targeting by an internet server
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
SE9600647D0 (sv) Ny användning
MXPA03004465A (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos.
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
ATE318834T1 (de) Lipide mit aminoxygruppe
AU2002215904A1 (en) Compounds with a branched linker
DE60041351D1 (de) Gssytem
ITGE950086A0 (it) Macchina operatrice, in particolare macchina impacchettatrice per sigarette, o simili.
WO2000003724A1 (fr) Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu&#39;ingredient actif
ITGE930034A1 (it) Macchina confezionatrice, in particolare macchina impacchettatrice, di sigarette o simili.
WO2001065606A3 (de) Feldeffekt-transistoranordnung mit hoher latch-up-festigkeit und verfahren zu deren herstellung
AU2002222695A1 (en) Novel 4&#39;-demethyl-4&#39;-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same
AU7384401A (en) Active substance conjugates with intracellularly active ligands
BG105372A (en) Immunogenic liposome compositions
AU2001273235A1 (en) Lipid metabolism molecules
ATE211383T1 (de) Topische aciclovir-zubereitung
IT1292630B1 (it) Macchina impacchettatrice di gruppi di sigarette.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties